The Transitional Drug Add-on Payment Adjustment (TDAPA) for phosphate binders will expire at the end of 2026, forcing DaVita to absorb these costs into its standard bundled payment rate.
Filing excerpt
On January 1, 2025, phosphate binders, a drug class taken orally by many ESKD patients to reduce absorption of dietary phosphate, were incorporated into the ESRD PPS bundled payment rate.
What this signalsFilings often name leadership changes, deals and spending plans.
Regions named
sec-10krecurringRevenueShiftGet every 10-K signal for DaVita and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at DaVita this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/94d7f663-62a2-4f24-85b7-2508c7e1d7e9 returns this record as JSON. POST /v1/companies/enrich returns every signal for davita.com.
{
"signal_id": "94d7f663-62a2-4f24-85b7-2508c7e1d7e9",
"signal_type": "sec-10k",
"signal_subtype": "recurringRevenueShift",
"detected_at": "2026-02-17T06:37:53.052+00:00",
"company": {
"name": "DaVita",
"domain": "davita.com"
},
"data": {
"detail": "The Transitional Drug Add-on Payment Adjustment (TDAPA) for phosphate binders will expire at the end of 2026, forcing DaVita to absorb these costs into its standard bundled payment rate. This creates an urgent need for cost-containment solutions and operational efficiency tools to mitigate margin compression.",
"metrics": {
"timeframe": "next_year"
},
"summary": "Facing financial pressure as drug add-on payments are set to expire at the end of 2026",
"excerpts": "On January 1, 2025, phosphate binders, a drug class taken orally by many ESKD patients to reduce absorption of dietary phosphate, were incorporated into the ESRD PPS bundled payment rate.",
"relevance": 0.9,
"sentiment": "negative",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/927066/000092706626000012/dva-20251231.htm",
"filing_date": "2026-02-11",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "Billing/subscription tools",
"signal_category": "revenue",
"regions_mentioned": [
"U.S."
]
}
}
curl https://signals.autobound.ai/v1/signals/94d7f663-62a2-4f24-85b7-2508c7e1d7e9 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"davita.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.